发明名称 Anvendelse av et rekombinant protein for fremstilling av et preparat for behandling av tilstander relatert til eksokrin bukspyttkjertelinsuffisiens
摘要 Bile-salt stimulated lipase (BSSL) may comprise amino acids 1-722, 1-535, 1-278, 1-341, 1-409, 1-474, 279-341, 279-409, 279-474, 342-409, 342-474 or 536-722 of the sequence given at the end. Also claimed are (1) a functionally equivalent variant or mutant of BSSL; (2) a DNA sequence (I) encloding BSSL, comprising nucleotides 151-2316, 151-1755, 151-985, 151-1172, 151-1376, 151-1574, 986-1172, 986-1376, 986-1574, 1173-1376 or 1173-1574 of the sequence given in the specification; (3) a vector comprising (I); and (4) a host organism transformed with the vector of (3); and (5) an infant food formulation comprising BSSL. Pref. BSSL may be in combination with one or more of the direct repeats of the sequence given in the specification. BSSL may posses Met as additional N-terminal amino acid.
申请公布号 NO322962(B1) 申请公布日期 2006.12.18
申请号 NO19920004528 申请日期 1992.11.24
申请人 AREXIS AB 发明人 BJURSELL GUNNAR;NILSSON JEANETTE;BLACKBERG LARS;HERNELL OLLE;CARLSSON PETER;ENERBACK SVEN;OLIVECRONA THOMAS
分类号 A23L1/30;A61K38/46;A61K8/36;A61K8/37;A61K8/42;A61K8/44;A61K8/49;A61K8/92;A61K38/00;A61P1/00;A61P3/06;A61Q5/02;A61Q19/00;A61Q19/10;C07K14/00;C11D1/02;C11D1/90;C11D1/94;C11D3/20;C12N9/16;C12N9/18;C12N9/20;C12N15/09;C12N15/55;C12P21/02 主分类号 A23L1/30
代理机构 代理人
主权项
地址